Beef Burger Versus a Vegetarian Burger

January 28, 2020 updated by: Cindy Kosch, Loma Linda University

A Comparison of the Rise of Serum Lipids, Glucose, and Hs-CRP Levels After Consumption of a Beef Burger Versus a Vegetarian Burger

The purpose of this graduate student research study is to compare the rise of serum lipids, glucose, and hs-CRP levels after consumption of a beef burger versus a vegetarian burger in healthy adults between the ages of 21 and 55

Study Overview

Status

Completed

Conditions

Detailed Description

Visit 1

  • Sign an informed consent.
  • Complete a brief questionnaire about demographics (age, gender, and race), eating habits, physical activity level, and medical history (known allergies, and history of dyslipidemia, diabetes mellitus, or arthritis)
  • Will be directed to fast for 8 hours prior to Visit 2. Visit 2
  • Be randomized into either Group 1 or Group 2. One group will eat the beef burger first and the other group will eat the vegetarian burger first.
  • Fill out a questionnaire on number of hours slept and current stress level.
  • Take a finger prick test (tiny drop of blood) to determine baseline measurements for serum lipids, glucose, and hs-CRP levels.
  • Consume either a beef burger or vegetarian burger.
  • Afterwards, remain in Nichol Hall, Room A112, for 2 hours (may study, watch a movie, etc.).
  • May not consume anything except for water.
  • After 30 min, 60 min, 120 min, finger prick tests will be used to measure post-consumption serum lipids, glucose, and hs-CRP levels.
  • Will be asked to try and identify burger consumed and rate the taste of the burger.
  • Will be directed to fast for 8 hours prior to Visit 3. Visit 3
  • Repeat the same procedure as Visit 2. However, this time the burgers will be switched.

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Loma Linda, California, United States, 92350
        • Loma Linda University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 53 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Healthy adults between 21 and 55 years of age
  • Consume both beef and vegetarian products
  • No distaste for whole wheat buns, lettuce, soy, tomatoes, or vegan mayonnaise
  • Willing to abstain from caffeine and exercise the morning of visits (2 days)

Exclusion criteria:

  • Those allergic to the following food items:

    • Gluten
    • Lettuce
    • Soy
    • Tomatoes
    • Vegan Mayonnaise
  • Have a known history of dyslipidemia, diabetes mellitus, or arthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: burger consumption group
Each participant will consume a burger with a whole wheat bun, lettuce, tomatoes, and vegan mayonnaise (free of cholesterol) for one meal. The burger patty will be 4 ounces. The beef patty (Beef Patty Chuck) will be 80% lean and 20% fat.

A finger prick test will be used to determine baseline levels measurements for serum lipids, glucose, and hs-CRP levels. Group 1 will be given vegetarian burgers to consume. Participants will need to remain in the room for 2 hours, postprandial (they may study, watch a movie, etc). They will not be allowed to consume anything except for water during this time. After consumption of burger, at 30 min, 60 min, 120 min, finger prick tests will be used to obtain blood. Participants will also be asked to try and identify the burger they consumed and rate the taste of the burger. Visit 2 will take approximately 3 hours.

  • Participants will be directed to fast for 8 hours prior to Visit 3 (the following week).
  • Visit 3: We will repeat the same procedure as Visit 2. However, this time the burgers will be switched.
Active Comparator: vegetarian burger consumption group
Each participant will consume a burger with a whole wheat bun, lettuce, tomatoes, and vegan mayonnaise (free of cholesterol) for one meal. The burger patty will be 4 ounces. The vegetarian patty (Impossible Burger) will be 18% fat.

A finger prick test will be used to determine baseline levels measurements for serum lipids, glucose, and hs-CRP levels. Group 2 will be given beef burgers to consume. Participants will need to remain in the room for 2 hours, postprandial (they may study, watch a movie, etc). They will not be allowed to consume anything except for water during this time. After consumption of burger, at 30 min, 60 min, 120 min, finger prick tests will be used to obtain blood. Participants will also be asked to try and identify the burger they consumed and rate the taste of the burger. Visit 2 will take approximately 3 hours.

  • Participants will be directed to fast for 8 hours prior to Visit 3 (the following week).
  • Visit 3: We will repeat the same procedure as Visit 2. However, this time the burgers will be switched.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
serum lipid panel concentration
Time Frame: change between visit 2(up to 7 days after initial study enrollment) and visit 3(exactly 7 days after Visit 2)
Finger prick tests (tiny drop of blood) will be used to measure serum lipids at baseline, and then at 30 minutes, 60 minutes, and 120 minutes postprandial to determine each participant's lipid profile.
change between visit 2(up to 7 days after initial study enrollment) and visit 3(exactly 7 days after Visit 2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
glucose blood concentration
Time Frame: change between visit 2(up to 7 days after initial study enrollment) and visit 3(exactly 7 days after Visit 2)
Finger prick tests (tiny drop of blood) will be used to measure glucose at baseline, and then at 30 minutes, 60 minutes, and 120 minutes postprandial to determine each participant's lipid profile.
change between visit 2(up to 7 days after initial study enrollment) and visit 3(exactly 7 days after Visit 2)
hs-CRP blood concentration
Time Frame: change between visit 2(up to 7 days after initial study enrollment) and visit 3(exactly 7 days after Visit 2)
Finger prick tests (tiny drop of blood) will be used to measure hs-CRP at baseline, and then at 30 minutes, 60 minutes, and 120 minutes postprandial to determine each participant's lipid profile.
change between visit 2(up to 7 days after initial study enrollment) and visit 3(exactly 7 days after Visit 2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cindy Kosch, MS, Loma Linda University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

January 28, 2020

Study Completion (Actual)

January 28, 2020

Study Registration Dates

First Submitted

July 19, 2019

First Submitted That Met QC Criteria

July 24, 2019

First Posted (Actual)

July 26, 2019

Study Record Updates

Last Update Posted (Actual)

January 30, 2020

Last Update Submitted That Met QC Criteria

January 28, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 5190215

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

Clinical Trials on vegetarian burger

3
Subscribe